Esperion to Participate in Upcoming Virtual Investor Conference
July 27 2021 - 8:00AM
Esperion (NASDAQ: ESPR), today announced that Sheldon Koenig,
president and chief executive officer of Esperion will participate
in the upcoming BTIG Virtual Biotechnology Conference.
Event: |
BTIG Virtual
Biotechnology Conference |
Date: |
August 9, 2021 |
Format: |
Fireside Chat |
Time: |
11:30 a.m. ET |
Live audio webcasts of these events can be accessed on the
investor relations section of the Esperion website at
www.esperion.com/investors-media/events-presentations/. Replays of
the webcasts will be archived on the Company's website for 90 days
following the events.
ESPERION Therapeutics
ESPERION is The Lipid Management Company. Our goal is lipid
management for everybody, that’s why we work hard to make our
medicines easy to get, easy to take and easy to have. We discover,
develop and commercialize innovative medicines and combinations to
lower cholesterol, especially for patients whose needs aren’t being
met by the status quo. Our entrepreneurial team of industry leaders
is inclusive, passionate and resourceful. We are singularly focused
on managing cholesterol so you can improve your health easily. For
more information, please visit www.esperion.com and follow us on
Twitter at www.twitter.com/EsperionInc.
Investor Contact:Kaitlyn
BroscoEsperioncorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024